Binningen, Switzerland

Stephan Dvorsky

This inventor holds 1 USPTO granted patent. Top assignee: Siegfried Aktiengesellschaft. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Dvorsky. Retrieved from https://idiyas.com/inventor/stephan-dvorsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Stephan Dvorsky

Introduction

Stephan Dvorsky is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. His innovative approach has led to the creation of a unique coronary therapeutic agent.

Latest Patents

Dvorsky holds a patent for a coronary therapeutic agent in the form of soft gelatin capsules. This invention addresses previous challenges related to capsule size and the low concentration of the active substance, nifedipine. By utilizing PVP and dissolving nifedipine in THFP, Dvorsky's invention allows for a capsule weight of only 162 mg, thus improving the efficacy and usability of the medication.

Career Highlights

Stephan Dvorsky is associated with Siegfried Aktiengesellschaft, a company known for its commitment to pharmaceutical innovation. His work has not only advanced the field but has also contributed to the company's reputation as a leader in therapeutic solutions.

Collaborations

Dvorsky has collaborated with esteemed colleagues such as Franz Radivojevich and Hans Joss. Their combined expertise has fostered an environment of innovation and has led to the successful development of new pharmaceutical products.

Conclusion

Stephan Dvorsky's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…